Pharmacology Watch – September 1, 2015
September 1, 2015
View Issues
-
New Research Weighs Benefits of Triple Therapy for Patients Who Have Undergone PCI
A new study suggests that more is perhaps not better.
-
FDA Actions
FDA fast-tracks approval of a new drug combination for treatment of heart failure; warns about medication errors for two drugs; approves first monoclonal anti-body as second-line treatment for high cholesterol; green lights oral medication for treatment of locally advanced basal cell carcinoma; and approves two new hepatitis C treatments.